Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Decoding the role of mitochondrial dynamics in the mesenchymal-to-amoeboid transition and melanoma metastasis

Project description

Mitochondria’s role in cancer cell invasion

The spread of cancer cells to distant organs from the original site remains the principal reason for cancer deaths. While mesenchymal-like cells are infamous for their invasive properties, it is amoeboid-type cells that are more aptly suited for metastasis. However, the biological switch between the two cell types, or the mesenchymal-to-amoeboid transition (MAT), remains little understood. Supported by the Marie Skłodowska-Curie Actions programme, the MitoMat project investigates how mitochondria are implicated in this process. Using microfluidic, optogenetic and proteomic technologies in combination, the project will shed light on how mitochondria assist in sustaining tumour cell movement and in melanoma. This kind of research holds the potential for the generation of new metastasis-directed therapies.

Objective

Tumor cell migration and invasion represent the foundation of cancer metastasis. It is therefore critical to better understand the
mechanisms driving a specific subset of tumor cells to invade nearby tissues. Invasive cells are known to have an undifferentiated,
mesenchymal-like state. However, under specific microenvironment conditions, mesenchymal cells become amoeboid, through a
process known as the mesenchymal-to-amoeboid transition (MAT). Paradoxically, it is not the mesenchymal cells that are more
metastatic-prone, but the amoeboid cells. What is not yet fully understood is the precise cellular mechanisms driving MAT. Emerging
evidence show that mitochondria are closely linked with cellular motility, especially in cancer. Mitochondrial dynamics, consisting
mainly in mitochondrial fusion, fission, intracellular trafficking and turnover, was proven to be involved in the migration of
mesenchymal-like tumor cells. However, very little is known about the characteristics of lamellipodia-localized mitochondria in these
cancer cells on one hand, and how it might influence MAT and the amoeboid phenotype on the other. Therefore, I first aim to
evaluate the role of mitochondrial dynamics in tumor microenvironment-triggered MAT during the 3D invasion of melanoma cells by
combining microfluidic and optogenetic approaches. Secondly, I will characterize the lamellipodia-localized mitochondria in terms of
proteome, age, energetic and oxidative status, in mesenchymal-like melanoma cells using biochemical, microfluidic and proteomic
approaches. By the end of the project, MitoMat would significantly improve the mechanistic understanding of how mitochondria are
hijacked to fuel cancer cell motility, specifically within melanoma cells with different MAT phenotypes. If mitochondrial dynamics
would prove to be a driver for both cell invasion modalities (mesenchymal and amoeboid), our results could represent the premises
for a future migrastatic therapy, targeting cancer metastasis.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Net EU contribution
€ 226 420,56
Address
RUE DE TOLBIAC 101
75654 Paris
France
Region
Ile-de-France Ile-de-France Paris
Activity type
Research Organisations
Links
Total cost
No data

Partners (1)